• 2024
  Ohki CMY, Benazzato C, van der Linden V, França JV, Toledo CM, Machado RRG, Araujo DB, Oliveira DBL, Neris RS, Assunção-Miranda I, de Oliveira Souza IN, Nogueira CO, Leite PEC, van der Linden H, Figueiredo CP, Durigon EL, Clarke JR, Russo FB, Beltrão-Braga PCB, Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome., Biochim Biophys Acta Mol Basis Dis 2024 Feb; (): 167097.
• 2024
  Souza MS, Farias JP, Andreata-Santos R, Silva MP, Brito RDDS, Duarte Barbosa da Silva M, Peter CM, Cirilo MVF, Luiz WB, Birbrair A, Vidal PO, de Castro-Amarante MF, Candido ED, Munhoz AS, de Mello Malta F, Dorlass EG, Machado RRG, Pinho JRR, Oliveira DBL, Durigon EL, Maricato JT, Braconi CT, Ferreira LCS, Janini LMR, Amorim JH, Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future., J Med Virol 2024 Feb; 96(2): e29416.
• 2024
  Machado RRG, Candido ÉD, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Durigon EL, Oliveira DBL, Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster., Vaccines (Basel) 2024 Jan; 12(2): .
• 2023
  Machado RRG, Walker JL, Scharton D, Rafael GH, Mitchell BM, Reyna RA, de Souza WM, Liu J, Walker DH, Plante JA, Plante KS, Weaver SC, Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters., Nat Commun 2023 Jul; 14(1): 4260.
• 2023
  Prudencio CR, Gomes da Costa V, Rocha LB, Costa HHM, Orts DJB, da Silva Santos FR, Rahal P, Lino NAB, da Conceição PJP, Bittar C, Machado RRG, Durigon EL, Araujo JP, Polatto JM, da Silva MA, de Oliveira JA, Mitsunari T, Pereira LR, Andreata-Santos R, de Souza Ferreira LC, Luz D, Piazza RMF, Identification of Zika Virus NS1-Derived Peptides with Potential Applications in Serological Tests., Viruses 2023 Feb; 15(3): .
• 2022
  Baker JM, Shah MM, O'Hegarty M, Pomeroy M, Keiser P, Ren P, Weaver SC, Maknojia S, Machado RRG, Mitchell BM, McConnell A, Tate JE, Kirking HL, Primary and Secondary Attack Rates by Vaccination Status after a SARS-CoV-2 B.1.617.2 (Delta) Variant Outbreak at a Youth Summer Camp-Texas, June 2021., J Pediatric Infect Dis Soc 2022 Dec; 11(12): 550-556.
• 2022
  Plante JA, Machado RRG, Mitchell BM, Shinde DP, Walker J, Scharton D, McConnell A, Saada N, Liu J, Khan B, Campos RK, Johnson BA, Menachery VD, Levine CB, Ren P, McLellan SLF, Plante KS, Weaver SC, Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients., Viruses 2022 Sep; 14(9): .
• 2022
  Liu Y, Liu J, Zou J, Kalveram B, Machado RRG, Ren P, Türeli S, Smith DJ, Weaver SC, Xie X, Shi PY, Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes., Signal Transduct Target Ther 2022 Aug; 7(1): 285.
• 2022
  Srinivasan V, Brognaro H, Prabhu PR, de Souza EE, Günther S, Reinke PYA, Lane TJ, Ginn H, Han H, Ewert W, Sprenger J, Koua FHM, Falke S, Werner N, Andaleeb H, Ullah N, Franca BA, Wang M, Barra ALC, Perbandt M, Schwinzer M, Schmidt C, Brings L, Lorenzen K, Schubert R, Machado RRG, Candido ED, Oliveira DBL, Durigon EL, Niebling S, Garcia AS, Yefanov O, Lieske J, Gelisio L, Domaracky M, Middendorf P, Groessler M, Trost F, Galchenkova M, Mashhour AR, Saouane S, Hakanpää J, Wolf M, Alai MG, Turk D, Pearson AR, Chapman HN, Hinrichs W, Wrenger C, Meents A, Betzel C, Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease., Commun Biol 2022 Aug; 5(1): 805.
• 2022
  Song ATW, Rocha V, Mendrone-Júnior A, Calado RT, De Santis GC, Benites BD, Costa-Lima C, Vargas T, Marques LS, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Avelino-Silva VI, Machado RRG, Durigon EL, Chevret S, Kallas EG, Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)., Lancet Reg Health Am 2022 Jun; 10(): 100216.
• 2022
  Nielsen MC, Machado RRG, Mitchell BM, McConnell AJ, Saada NI, Weaver SC, Ren P, A Comparison of Seegene Technologies Novaplex SARS-CoV-2 Variants I, II, and IV Assays with Spike Gene Sequencing for Detection of Known Severe Acute Respiratory Syndrome Coronavirus 2 Variants., J Mol Diagn 2022 May; 24(5): 455-461.
• 2022
  Zou J, Xia H, Xie X, Kurhade C, Machado RRG, Weaver SC, Ren P, Shi PY, Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection., Nat Commun 2022 Feb; 13(1): 852.
• 2022
  Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL, Parolo E, Pellegrini JAS, Viana MV, Schwarz P, Lisboa TC, Dora JMS, Portich JP, Paz AA, Silla L, Balsan AM, Schirmer FD, Franz JPM, da-Silveira LM, Breunig RC, Petersen V, Sosnoski M, Mesquita NF, Volpato FCZ, Sganzerla D, Falavigna M, Rosa RG, Zavascki AP, Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial., Eur Respir J 2022 Feb; 59(2): .
• 2022
  Oliveira JR, Ruiz CMR, Machado RRG, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, de Medeiros GX, Júnior RCVS, Durigon EL, Boscardin SB, Rosa DS, Schechtman D, Nakaya HI, Cunha-Neto E, Gadermaier G, Kalil J, Coelho V, Santos KS, Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape., Front Immunol 2022 ; 13(): 1010105.
• 2022
  Andreata-Santos R, Machado RRG, Alves RPDS, Sales NS, Soares CP, Rodrigues KB, Silva MO, Favaro MTP, Rodrigues-Jesus MJ, Yamamoto MM, de Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LCS, Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil., Front Cell Infect Microbiol 2022 ; 12(): 787411.
• 2022
  Silva EKVB, Bomfim CG, Barbosa AP, Noda P, Noronha IL, Fernandes BHV, Machado RRG, Durigon EL, Catanozi S, Rodrigues LG, Pieroni F, Lima SG, Teodoro WR, Queiroz ZAJ, Silveira LKR, Charlie-Silva I, Capelozzi VL, Guzzo CR, Fanelli C, Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats., PLoS One 2022 ; 17(5): e0268434.
• 2021
  Bertanha M, Rodrigues LDS, Mellucci Filho PL, Moroz A, Pardini MIMC, Sobreira ML, Durigon EL, Machado RRG, Grotto RMT, Lima MA, Nader HB, Moraes ML, Barbosa AN, Medolago NB, Cardoso FF, Magro AJ, Carvalho CRG, Moraes LN, Alvarado RC, Nunes HC, Campos GC, Grillo VTRDS, Sertorio ND, Fortaleza CMCB, Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: Triple-blind clinical trial., Medicine (Baltimore) 2021 Dec; 100(51): e28288.
• 2021
  Wendel S, Fachini R, Fontão-Wendel RCL, Mello R, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL, Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?, Transfusion 2021 Dec; 61(12): 3455-3467.
• 2021
  Machado RRG, Glaser T, Araujo DB, Petiz LL, Oliveira DBL, Durigon GS, Leal AL, Pinho JRR, Ferreira LCS, Ulrich H, Durigon EL, Guzzo CR, Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 Replication by Hypertonic Saline Solution in Lung and Kidney Epithelial Cells., ACS Pharmacol Transl Sci 2021 Oct; 4(5): 1514-1527.
• 2021
  da Silva Santos PS, da Fonseca Orcina B, Machado RRG, Vilhena FV, da Costa Alves LM, Zangrando MSR, de Oliveira RC, Soares MQS, Simão ANC, Pietro ECIN, Kuroda JPG, de Almeida Benjamim IA, Araujo DB, Toma SH, Flor L, Araki K, Durigon EL, Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial., Sci Rep 2021 Oct; 11(1): 19937.
• 2021
  Venceslau-Carvalho AA, Teixeira de Pinho Favaro M, Ramos Pereira L, Rodrigues-Jesus MJ, Santos Pereira S, Andreata-Santos R, Dos Santos Alves RP, Castro-Amarante MF, Bitencourt Rodrigues K, Ramos da Silva J, Rahal Guaragna Machado R, Dos Passos Cunha M, Marinho de Andrade Zanotto P, Luzetti Fotoran W, Wunderlich G, Durigon EL, de Souza Ferreira LC, Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies., Nanomedicine 2021 Oct; 37(): 102445.
• 2021
  Jaworski E, Langsjoen RM, Mitchell B, Judy B, Newman P, Plante JA, Plante KS, Miller AL, Zhou Y, Swetnam D, Sotcheff S, Morris V, Saada N, Machado RR, McConnell A, Widen SG, Thompson J, Dong J, Ren P, Pyles RB, Ksiazek TG, Menachery VD, Weaver SC, Routh AL, Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants., Elife 2021 Sep; 10(): .
• 2021
  Yokoyama APH, Wendel S, Bonet-Bub C, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Fontão-Wendel R, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Filho RK, Marra AR, Amano MT, Kallás EG, Helito AS, de Carvalho CRR, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM, COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes., Transfusion 2021 Aug; 61(8): 2295-2306.
• 2021
  de Freitas Dutra V, Bonet-Bub C, Yokoyama APH, Achkar R, Machado RRG, Assunção M, Candelária G, Soares CP, Fachini RM, Fontão-Wendel R, Hamerschlak N, Reis LFL, Araujo DB, Nudelman V, Pinho JRR, Rizzo LV, Sakashita AM, Scuracchio P, Durigon EL, Wendel S, Kutner JM, Anti-A and SARS-CoV-2: an intriguing association., Vox Sang 2021 May; 116(5): 557-563.
• 2021
  Wendel S, Fontão-Wendel R, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado R, Araujo D, Soares C, Durigon E, A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections., Transfusion 2021 May; 61(5): 1447-1460.
• 2021
  Fajardo TCG, Gazeta RE, Catalan DT, Mello AS, Silva ACBD, Bertozzi APAP, Santos GRD, Pinto CAL, Monteiro CO, Machado RRG, Oliveira DBL, Durigon EL, Passos SD, Neonatal consequences of maternal exposure to the chikungunya virus: Case reports., Medicine (Baltimore) 2021 Apr; 100(17): e25695.
• 2021
  Mendrone-Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, de Almeida Neto C, Hamasaki DT, Facincani T, de Oliveira Alves LB, Machado RRG, Araujo DB, Durigon EL, Rocha V, Sabino EC, Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing., Transfusion 2021 Apr; 61(4): 1181-1190.
• 2021
  Lopes AGD, Celestino CSH, Barros TTA, Fevereiro AG, Gejer DH, Oliveira FMF, Brasil JM, Bossolan RM, Pinto GCC, Santos ACEZ, Divan LA, Alves IAB, Oliveira DBL, Machado RRG, Thomazelli LM, Hiyane MI, Brelaz-Abreu L, Bragança-Jardim E, Heinen LBS, Barrientos ACM, Mau LB, Camara NOS, Bueno DF, Amano MT, Case Report: A Severe SARS-CoV-2 Infection in a Teenager With Angelman Syndrome., Front Med (Lausanne) 2021 ; 8(): 629112.
• 2020
  Wendel S, Kutner JM, Machado R, Fontão-Wendel R, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Dal Ben M, Araujo D, Soares C, Camargo A, Kallás E, Durigon E, Reis LF, Rizzo LV, Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program., Transfusion 2020 Dec; 60(12): 2938-2951.
• 2020
  Sabino CP, Sellera FP, Sales-Medina DF, Machado RRG, Durigon EL, Freitas-Junior LH, Ribeiro MS, UV-C (254 nm) lethal doses for SARS-CoV-2., Photodiagnosis Photodyn Ther 2020 Dec; 32(): 101995.
• 2020
  De Paulis M, Oliveira DBL, Vieira RP, Pinto IC, Machado RRG, Cavalcanti MP, Soares CP, de Araujo AMP, Araujo DB, Bachi ALL, Leal FB, Dorlass EG, Gilio AE, Durigon EL, Barreira ER, Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report., Pediatr Infect Dis J 2020 Oct; 39(10): e321-e324.
• 2020
  Dorlass EG, Monteiro CO, Viana AO, Soares CP, Machado RRG, Thomazelli LM, Araujo DB, Leal FB, Candido ED, Telezynski BL, Valério CA, Chalup VN, Mello R, Almeida FJ, Aguiar AS, Barrientos ACM, Sucupira C, De Paulis M, Sáfadi MAP, Silva DGBP, Sodré JJM, Soledade MP, Matos SF, Ferreira SR, Pinez CMN, Buonafine CP, Pieroni LNF, Malta FM, Santana RAF, Souza EC, Fock RA, Pinho JRR, Ferreira LCS, Botosso VF, Durigon EL, Oliveira DBL, Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR., Braz J Microbiol 2020 Sep; 51(3): 1117-1123.
• 2020
  Araujo DB, Machado RRG, Amgarten DE, Malta FM, de Araujo GG, Monteiro CO, Candido ED, Soares CP, de Menezes FG, Pires ACC, Santana RAF, Viana AO, Dorlass E, Thomazelli L, Ferreira LCS, Botosso VF, Carvalho CRG, Oliveira DBL, Pinho JRR, Durigon EL, SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network., Mem Inst Oswaldo Cruz 2020 ; 115(): e200342.
• 2020
  Bittar C, Machado RRG, Comelis MT, Bueno LM, Beguelini MR, Morielle-Versute E, Nogueira ML, Rahal P, Alphacoronavirus Detection in Lungs, Liver, and Intestines of Bats from Brazil., Microb Ecol 2020 Jan; 79(1): 203-212.
• 2020
  Slavov SN, Guaragna Machado RR, Ferreira AR, Soares CP, Araujo DB, Leal Oliveira DB, Covas DT, Durigon EL, Kashima S, Zika virus seroprevalence in blood donors from the Northeastern region of São Paulo State, Brazil, between 2015 and 2017., J Infect 2020 Jan; 80(1): 111-115.
• 2019
  Favoretto SR, Araujo DB, Duarte NFH, Oliveira DBL, da Crus NG, Mesquita F, Leal F, Machado RRG, Gaio F, Oliveira WF, Zanotto PMA, Durigon EL, Zika Virus in Peridomestic Neotropical Primates, Northeast Brazil., Ecohealth 2019 Mar; 16(1): 61-69.
• 2018
  Bittar C, Machado RRG, Comelis MT, Bueno LM, Morielle-Versute E, Beguelini MR, de Souza RP, Nogueira ML, Rahal P, Lack of serological and molecular evidence of arbovirus infections in bats from Brazil., PLoS One 2018 ; 13(11): e0207010.